A carregar...
Severe Hepatotoxicity due to Ibrutinib with a Review of Published Cases
Ibrutinib, an irreversible Bruton's tyrosine kinase inhibitor, is an effective treatment for Waldenström's macroglobulinemia, chronic lymphocytic leukemia, and several other types of lymphoma. Studies prior to FDA approval in 2015 failed to demonstrate any hepatotoxicity. However, since th...
Na minha lista:
| Publicado no: | Case Rep Gastroenterol |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
S. Karger AG
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6787434/ https://ncbi.nlm.nih.gov/pubmed/31607836 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000502605 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|